Welcome

Gilead’s Coronavirus Drug Results Likely in a Few Months

March 3, 2020, 7:53 PM

A treatment for the coronavirus could be available in the next several months if an experimental drug by Gilead Sciences Inc. proves to work, the NIH’s infectious disease chief said.

Gilead is testing the antiviral remdesivir in two phase III clinical trials—the large studies needed to win FDA approval—in China’s Hubei province as well as in a U.S. trial led by the National Institute of Allergy and Infectious Diseases (NIAID) in the National Institutes of Health.

“We should know within a period of a few months, several months, whether or not this particular drug works,” NIAID Director Anthony S. Fauci ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.